Option Care Health Announces Secondary Offering of 11,000,000 Shares of Common Stock

Rhea-AI Summary

Option Care Health announced an underwritten secondary offering of 11 million shares by an affiliate of Walgreens Boots Alliance, representing approximately 6.0% of its outstanding shares. The offering, managed by Goldman Sachs, will not generate proceeds for the company. A shelf registration statement has been filed with the SEC to facilitate this process. Although the offering can potentially affect stock availability, it is not expected to impact the company's financial position directly.

Positive

• Completion of secondary offering may enhance liquidity and market presence.
• Involvement of reputable underwriter Goldman Sachs indicates confidence in the transaction.

Negative

• The offering dilutes existing shareholders' stakes as it increases the total shares outstanding.
• The company will not receive any proceeds from the offering, limiting its ability to invest in growth initiatives.

BANNOCKBURN, Ill., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 11,000,000 shares of the Company’s common stock in an underwritten secondary offering. The Company will not receive any proceeds from the offering.

This sale of shares represents approximately 6.0% of the current shares outstanding. Goldman Sachs & Co. LLC is acting as the sole underwriter for the offering.

A shelf registration statement on Form S-3 relating to the shares of common stock was filed with, and declared effective by, the Securities and Exchange Commission (the “SEC”). The offering may be made only by means of a prospectus supplement and the accompanying prospectus, which will be filed with the SEC. You may get these documents for free by visiting the SEC’s website at www.sec.gov. Alternatively, copies may be obtained from:

Goldman Sachs & Co. LLC
Attn: Prospectus Department
200 West Street
New York, New York 10282
Tel: 866.471.2526
Email: Prospectus-ny@ny.email.gs.com

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor may there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 7,500 team members including more than 4,500 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members.

Forward-Looking Statements - Safe Harbor

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include statements about the Company’s ability to consummate the offering and the Company’s use of proceeds from the offering.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. For a detailed discussion of the factors that could affect our actual results and financial condition, please refer to the risk factors identified in our SEC reports, including, but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

For Investor Inquiries:
Mike Shapiro, Chief Financial Officer
Option Care Health
312.940.2538
Investor.relations@optioncare.com 

FAQ

What does the secondary offering by Walgreens Boots Alliance mean for OPCH?

The secondary offering means that Walgreens Boots Alliance is selling 11 million shares of OPCH, which could affect stock availability and liquidity.

How many shares is Walgreens selling in the OPCH offering?

Walgreens is selling 11 million shares of Option Care Health in the secondary offering.

What percentage of OPCH's total shares does the offering represent?

The offering represents approximately 6.0% of Option Care Health's current outstanding shares.

Who is the underwriter for the OPCH secondary offering?

Goldman Sachs & Co. LLC is acting as the sole underwriter for the offering.

Will Option Care Health receive any funds from the secondary offering?

No, Option Care Health will not receive any proceeds from this secondary offering.